Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) has 103 institutional investors that have filed 13F reports for the period ending December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| T. Rowe Price Investment Management, Inc. | 31 Dec, 2025 | 12,938,821 | 2,194,714 | 20.43% | $31,443.00 |
| NEA Management Company, LLC | 31 Dec, 2025 | 4,448,757 | 0 | 0.00% | $10,810,480.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 2,188,857 | 0 | 0.00% | $5,318,922.00 |
| ACADIAN ASSET MANAGEMENT LLC | 31 Dec, 2025 | 1,630,173 | 1,149,050 | 238.83% | $3,956.00 |
| MARSHALL WACE, LLP | 31 Dec, 2025 | 1,110,088 | -189,120 | -14.56% | $2,697,515.00 |
| Siren, L.L.C. | 31 Dec, 2025 | 1,046,517 | 0 | 0.00% | $2,543,036.00 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 31 Dec, 2025 | 1,040,468 | 143,615 | 16.01% | $2,528,337.00 |
| JANE STREET GROUP, LLC | 31 Dec, 2025 | 961,776 | 724,503 | 305.35% | $2,337,115.00 |
| RENAISSANCE TECHNOLOGIES LLC | 31 Dec, 2025 | 949,735 | 350,335 | 58.45% | $2,307,856.00 |
| BlackRock, Inc. | 31 Dec, 2025 | 888,260 | -139,832 | -13.60% | $2,158,472.00 |
| Vestal Point Capital, LP | 31 Dec, 2025 | 870,000 | -4,680,000 | -84.32% | $2,114,100.00 |
| DIMENSIONAL FUND ADVISORS LP | 31 Dec, 2025 | 857,015 | 401,145 | 88.00% | $2,082,832.00 |
| D. E. Shaw & Co., Inc. | 31 Dec, 2025 | 655,772 | 512,129 | 356.53% | $1,593,526.00 |
| Connor, Clark & Lunn Investment Management Ltd. | 31 Dec, 2025 | 654,699 | 523,064 | 397.36% | $1,590,919.00 |
| Goldman Sachs Group Inc | 31 Dec, 2025 | 650,654 | 201,636 | 44.91% | $1,581,090.00 |
| AWM Investment Company, Inc. | 31 Dec, 2025 | 625,000 | 25,000 | 4.17% | $1,518,750.00 |
| FMR LLC | 31 Dec, 2025 | 541,154 | 87,596 | 19.31% | $1,315,005.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 505,780 | 5,257 | 1.05% | $1,229,422.00 |
| Northern Trust Corp | 31 Dec, 2025 | 472,702 | -15,362 | -3.15% | $1,148,666.00 |
| CITADEL ADVISORS LLC | 31 Dec, 2025 | 425,459 | 425,459 | 0.00% | $1,033,865.00 |